Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 341Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

ORIGINAL ARTICLE

Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006–2017

Neha Reddy, Subeesh Viswam, Beulah Elsa, Gouri Nair, Maheswari Eswaran

Year : 2020| Volume: 11| Issue : 1 | Page no: 24-30

   This article has been cited by
 
1 The Development of Human Papillomavirus (HPV) Vaccines and Current Barriers to Implementation
Rebecca Butterfield,Salimah Dhanani
Immunological Investigations. 2021; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Investigation on Spontaneous Abortion and Human Papillomavirus Infection
Mauro Tognon,Andrea Tagliapietra,Federica Magagnoli,Chiara Mazziotta,Lucia Oton-Gonzalez,Carmen Lanzillotti,Fortunato Vesce,Carlo Contini,John Charles Rotondo,Fernanda Martini
Vaccines. 2020; 8(3): 473
[Pubmed]  [Google Scholar] [DOI]
3 Post-approval Safety Monitoring of Quadrivalent and Bivalent Human Papillomavirus Vaccines Based on Real-world Data from the Korea Adverse Events Reporting System (KAERS)
MoonJung Kim,SangHee Kim,Ju-Young Shin
Clinical Drug Investigation. 2020;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article